OR WAIT null SECS
- Advertise
- About Us
- Editorial Board
- Contact Us
- Job Board
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Infection Control Today. All rights reserved.
JANUARY REFERENCES
JANUARY REFERENCES
"The Impact of Healthcare Legislation on Infection Control," byKathy Dix, page 30
2. http://www.apic.org/govt/OSHATBComments200204.doc
3. www.cbo.gov/showdoc.cfm?index=3910&sequence=0&from=7
"New IV Guidelines: What's Most Critical to Know," by RitaMcCormick, RN, CIC and Laura Rutledge, RN, MN, CRNI, page 43
1. CDC, National Nosocomial Infections Surveillance (NNIS) System report,data summary from October 1986-April 1998; issued June 1998. Am J InfectControl. 1998; 26:522-33.
2. CDC, National Nosocomial Infections Surveillance (NNIS) System report,data summary from January 1990-May 1999; issued June 1999. Am J Infect Control.1999; 27:520-32.
3. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiologyof nosocomial infection. Am J Med. 1991; 91 (suppl): S72-S75.
4. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome ofintravenous catheter-related infections in critically ill patients. Am J RespirCrit Care 2000; 162:1027-30.
5. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA.Increased resource use associates with catheter-related bloodstream infection inthe surgical intensive care unit. Arch Surg. 2001; 136:229-34.
6. Mermel LA. Correction: catheter-related bloodstream infections. Ann InternMed. 2000; 133:395.
7. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis andepidemiology of catheter-related infection with pulmonary artery Swan-Ganzcatheter: a prospective study utilizing molecular subtyping. Am J Med 1991; 91 (suppl):S197-S205.
8. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venouscatheter-related infections by using maximal sterile barrier precautions duringinsertion. Infect Control Hosp Epidemiol. 1994; 15:231-8.
9. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine,alcohol and chlorhexidine for prevention of infection associated with centralvenous and arterial catheters. Lancet. 1991; 338:339-43.
10. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trialof 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneousantisepsis for prevention of central venous catheter infection. Clin Infect Dis.2000;31:1001-7.
11. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-relatedsepsis: prospective, randomized study of three methods of long-term cathetermaintenance. Crit Care Med. 1990; 18:1073-9.
12. Uldall PR, Merchant N, Woods F, Yarworski U, Vas S. Changing subclavianhaemodialysis cannulas to reduce infection. Lancet. 1981; 1:1373.
13. Raad II, Darouiche R, Dupuis J, et al. Central venous catheters coatedwith minocycline and rifampin for the prevention of catheter-relatedcolonizations and bloodstream infections: a randomized, double-blind trial. TheTexas Medical Center Catheter Study Group. Ann Intern Med 1997; 127:267-74.
14. Nehme AE. Nutritional support of the hospitalized patient: the teamconcept. JAMA 1980; 243:1906-8.
15. Soifer NE, Borzak S, Edline BR, Weinstein RA. Prevention of peripheralvenous catheter complications with am intravenous therapy team: a randomizedcontrolled trial. Arch Intern Med. 1998; 158:473-7.
16. Tomford JW, Hershey CO. The IV therapy team: impact on patient care andcosts of hospitalization. NITA 1985; 8:387-9.